WAKEFIELD, Mass.--(BUSINESS WIRE)--Myrtelle Inc., (“Myrtelle” or the “Company”), a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on a new draft guideline clarifying how a company can initiate the regulatory review process for a major new ...

Access to essential cancer medicines is a major determinant of childhood cancer outcomes globally. The degree to which pediatric oncologists deem medicines listed on WHO's Model List of Essential ...

The ability of artificial intelligence (AI) tools to generate new insights and improve processes could enhance the development and regulation of medicines in areas ranging from preclinical research to ...

Tumor classification systems provide the language that allows teams of physicians and health care workers to communicate clearly about neoplasms, their natural histories, and their likely responses to ...